-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

561 Sympathetic Neuron Expressed Neuropeptide Y Is Crucial for Bone Marrow Niche Function and Hematopoietic Stem Cell Repopulation

Program: Oral and Poster Abstracts
Type: Oral
Session: 506. Bone Marrow Microenvironment: The Bone Marrow Microenvironment in Normal Hematopoiesis
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Translational Research, Hematopoiesis, Diseases, Biological Processes, Technology and Procedures
Sunday, December 8, 2024: 12:30 PM

Dinisha Kamble, PhD*, Yan QI, BS* and Pratibha Singh, PhD

Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN

The bone marrow (BM) microenvironment comprises a complex network of blood vessels and mesenchymal stromal cells (MSC) and is innervated by sympathetic nerve fibers. These BM niche components' soluble factors are pivotal for hematopoietic stem/progenitor cell (HSPC) function. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide produced by several cell types in the BM, including nerve fibers, hematopoietic cells, and stromal cells. Using germline NPY knockout (KO) mouse models and pharmacological NPY supplementation in mice, we and others showed that NPY can prevent BM niche damage and support hematopoietic regeneration. However, the germline NPY deficiency in all cell types may lead to compensatory changes in the hematopoietic system, and the function of sympathetic neuron-specific NPY in the BM niche and HSPC is unknown. In this study, we discovered that sympathetic neuron-specific NPY gene deletion in mice impairs HSC repopulation and attenuates BM niche restoration. To test the effect of sympathetic neuron-specific NPY deficiency on BM niche and HSPC function, we first bred NPY floxed (NPYfl/fl) mice with tamoxifen-inducible tyrosine hydroxylase Cre (TH-2A-CreER) mice and generated sympathetic neuron-specific NPY conditional KO mice (TH-Cre NPYfl/fl mice). To induce NPY gene deletion, three-month-old NPYfl/fl control mice and sympathetic neuron-specific NPY KO, TH-Cre NPYfl/fl mice were treated with tamoxifen (2 mg/mouse; 5 consecutive days). Two weeks post-treatment, the HSPC and BM niche of these mice were evaluated by flow cytometry and functional assays. Compared to NPYfl/fl mice, TH-Cre NPYfl/fl mice showed increased HSC-enriched SLAM LSK counts (1.6 fold, p≤ 0.001) and decreased the HPC clonal expansion (1.2 fold, p≤0.01) in the BM. TH-Cre NPYfl/fl mice SLAM LSK showed increased reactive oxygen species (ROS) production. These alterations in HSPCs of TH-Cre NPYfl/fl mice were accompanied by a substantial reduction in HSC-supporting factors in the BM, including angiopoietin, VEGF, SDF-1, and HGF (p≤0.02). To examine if sympathetic neuron-specific NPY deficiency influences HSC repopulation ability, we performed competitive transplantation using BM donor cells from NPYfl/fl or TH-Cre NPYfl/fl mice (C57BL/6) mixed with competitor cells (Boy J; 1:1 ratio) and transplanted into lethally irradiated wild-type (WT) recipient mice (F1 hybrid mice). TH-Cre NPYfl/fl mice donor cells showed reduced hematopoietic engraftment than NPYfl/fl mice donor cells (33%, p≤0.01). Moreover, TH-Cre NPYfl/fl mice donor cells showed increased myeloid differentiation (1.3 fold higher than NPYfl/fl , p≤0.05). High-dose irradiation/ chemotherapy routinely used in patients undergoing HSC transplantation causes nerve damage in the BM and impairs hematopoietic regeneration. To test the impact of sympathetic neuron-specific NPY deficiency on BM niche ability to support hematopoietic reconstitution after transplantation, we injected WT donor cells (2 million) into lethally irradiated NPYfl/fl and TH-Cre NPYfl/fl recipient mice (NPY deletion prior to transplantation). TH-Cre NPYfl/fl recipient mice demonstrated significantly fewer SLAM LSK, LSK, and hematopoietic cell recovery than NPYfl/fl mice at seven days post-transplantation (p≤0.05). We next investigated sympathetic neuron-NPY deficiency impact on WT HSPC homing. Compared to NPYfl/fl recipient mice, TH-Cre NPYfl/fl recipient mice exhibited reduced WT donor HSPC homing (2fold, p≤0.01). The reduction in HSPC homing and hematopoietic recovery observed in TH-Cre NPYfl/fl was accompanied by an increased loss of ECs (CD45-Ter119-CD31+VE-cadherin+) in the BM. To identify the potential molecular mechanism associated with NPY gene deletion contributing to impaired BM niche restoration, we performed RNA sequencing analysis of EC of WT and NPY KO mice. EC from NPY KO mice showed impaired expression of genes involved in pathways regulating antioxidant defense (Gpx3, Prdx4, Gpx3, Sod3, Srxn1, p<0.05) and DNA damage repair (Trp53i11, PARP, Gadd45a, Ddit4l, Rad51, p<0.05) compared to WT mice ECs. These findings revealed the previously unrecognized role of sympathetic neurons produced NPY in regulating BM niche function and HSC repopulation. Thus, preventing the NPY-producing sympathetic neuron damage during myeloablative irradiation/chemotherapy can improve BM restoration and hematopoietic reconstitution.

Disclosures: No relevant conflicts of interest to declare.

*signifies non-member of ASH